144 related articles for article (PubMed ID: 38759132)
1. Neuropathologic Validation and Diagnostic Accuracy of Presynaptic Dopaminergic Imaging in the Diagnosis of Parkinsonism.
Hastings A; Cullinane P; Wrigley S; Revesz T; Morris HR; Dickson JC; Jaunmuktane Z; Warner TT; De Pablo-Fernández E
Neurology; 2024 Jun; 102(11):e209453. PubMed ID: 38759132
[TBL] [Abstract][Full Text] [Related]
2. Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses.
Badoud S; Van De Ville D; Nicastro N; Garibotto V; Burkhard PR; Haller S
Neuroimage Clin; 2016; 12():234-40. PubMed ID: 27489771
[TBL] [Abstract][Full Text] [Related]
3. Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP.
Kim YJ; Ichise M; Ballinger JR; Vines D; Erami SS; Tatschida T; Lang AE
Mov Disord; 2002 Mar; 17(2):303-12. PubMed ID: 11921116
[TBL] [Abstract][Full Text] [Related]
4. Dopamine transporter SPECT imaging in Parkinson's disease and atypical Parkinsonism: a study of 137 patients.
Constantinides VC; Souvatzoglou M; Paraskevas GP; Chalioti M; Stefanis L; Kapaki E
Neurol Sci; 2023 May; 44(5):1613-1623. PubMed ID: 36658411
[TBL] [Abstract][Full Text] [Related]
5. Dopamine transporter imaging in progressive supranuclear palsy: Severe but nonspecific to subtypes.
Chen QS; Li XY; Li L; Lu JY; Sun YM; Liu FT; Zuo CT; Wang J
Acta Neurol Scand; 2022 Sep; 146(3):237-245. PubMed ID: 35611608
[TBL] [Abstract][Full Text] [Related]
6. Presynaptic Striatal Dopaminergic Function in Atypical Parkinsonism: A Metaanalysis of Imaging Studies.
Kaasinen V; Kankare T; Joutsa J; Vahlberg T
J Nucl Med; 2019 Dec; 60(12):1757-1763. PubMed ID: 30979821
[TBL] [Abstract][Full Text] [Related]
7. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.
Oh M; Kim JS; Kim JY; Shin KH; Park SH; Kim HO; Moon DH; Oh SJ; Chung SJ; Lee CS
J Nucl Med; 2012 Mar; 53(3):399-406. PubMed ID: 22323779
[TBL] [Abstract][Full Text] [Related]
8. [123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration.
Pirker W; Asenbaum S; Bencsits G; Prayer D; Gerschlager W; Deecke L; Brücke T
Mov Disord; 2000 Nov; 15(6):1158-67. PubMed ID: 11104200
[TBL] [Abstract][Full Text] [Related]
9. A novel computer-assisted image analysis of [123I]β-CIT SPECT images improves the diagnostic accuracy of parkinsonian disorders.
Goebel G; Seppi K; Donnemiller E; Warwitz B; Wenning GK; Virgolini I; Poewe W; Scherfler C
Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):702-10. PubMed ID: 21174092
[TBL] [Abstract][Full Text] [Related]
10. Pre- and postsynaptic dopamine SPECT in idiopathic Parkinsonian diseases: a follow-up study.
Jakobson Mo S; Linder J; Forsgren L; Holmberg H; Larsson A; Riklund K
Biomed Res Int; 2013; 2013():143532. PubMed ID: 24163811
[TBL] [Abstract][Full Text] [Related]
11. PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage.
Kurata T; Kametaka S; Ohta Y; Morimoto N; Deguchi S; Deguchi K; Ikeda Y; Takao Y; Ohta T; Manabe Y; Sato S; Abe K
Intern Med; 2011; 50(22):2775-81. PubMed ID: 22082889
[TBL] [Abstract][Full Text] [Related]
12. Automated Differential Diagnosis of Early Parkinsonism Using Metabolic Brain Networks: A Validation Study.
Tripathi M; Tang CC; Feigin A; De Lucia I; Nazem A; Dhawan V; Eidelberg D
J Nucl Med; 2016 Jan; 57(1):60-6. PubMed ID: 26449840
[TBL] [Abstract][Full Text] [Related]
13. Differential diagnosis of parkinsonian syndromes using dopamine transporter and perfusion SPECT.
Takaya S; Sawamoto N; Okada T; Okubo G; Nishida S; Togashi K; Fukuyama H; Takahashi R
Parkinsonism Relat Disord; 2018 Feb; 47():15-21. PubMed ID: 29157745
[TBL] [Abstract][Full Text] [Related]
14. Extrastriatal
Nicastro N; Fleury V; Broc N; Burkhard PR; Garibotto V
Parkinsonism Relat Disord; 2020 Sep; 78():38-43. PubMed ID: 32698058
[TBL] [Abstract][Full Text] [Related]
15. Scan without evidence of dopaminergic deficit (SWEDD) in degenerative parkinsonism and dementia with Lewy bodies: A prospective study.
Nicastro N; Burkhard PR; Garibotto V
J Neurol Sci; 2018 Feb; 385():17-21. PubMed ID: 29406901
[TBL] [Abstract][Full Text] [Related]
16. Dopaminergic Correlates of Regional Cerebral Blood Flow in Parkinsonian Disorders.
Nakano Y; Hirano S; Kojima K; Li H; Sakurai T; Suzuki M; Tai H; Furukawa S; Sugiyama A; Yamanaka Y; Yamamoto T; Iimori T; Yokota H; Mukai H; Horikoshi T; Uno T; Kuwabara S
Mov Disord; 2022 Jun; 37(6):1235-1244. PubMed ID: 35285050
[TBL] [Abstract][Full Text] [Related]
17. 123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Antonini A; Benti R; De Notaris R; Tesei S; Zecchinelli A; Sacilotto G; Meucci N; Canesi M; Mariani C; Pezzoli G; Gerundini P
Neurol Sci; 2003 Oct; 24(3):149-50. PubMed ID: 14598060
[TBL] [Abstract][Full Text] [Related]
18. Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice.
Ba F; Martin WR
Parkinsonism Relat Disord; 2015 Feb; 21(2):87-94. PubMed ID: 25487733
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal Change of DAT SPECT in Parkinson's Disease and Multiple System Atrophy.
Sakakibara S; Hashimoto R; Katayama T; Kenjyo M; Yokokawa Y; Saito Y; Hirakawa A; Ito M; Nakamura T; Hara K; Hashizume A; Aiba I; Inukai A; Katsuno M
J Parkinsons Dis; 2020; 10(1):123-130. PubMed ID: 31707374
[TBL] [Abstract][Full Text] [Related]
20. Decoding the dopamine transporter imaging for the differential diagnosis of parkinsonism using deep learning.
Zhao Y; Wu P; Wu J; Brendel M; Lu J; Ge J; Tang C; Hong J; Xu Q; Liu F; Sun Y; Ju Z; Lin H; Guan Y; Bassetti C; Schwaiger M; Huang SC; Rominger A; Wang J; Zuo C; Shi K
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2798-2811. PubMed ID: 35588012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]